Outcomes in Older Versus Younger Patients Over 96 Weeks in HIV-1– Infected Patients Treated with Rilpivirine or Efavirenz in ECHO and THRIVE§

OBJECTIVES: Increasing life expectancy of HIV-1–infected patients raises interest in how trial results apply to older patients. This post-hoc analysis evaluated potential differences in efficacy and safety in older (≥50 years) versus younger (<50 years) patients in the ECHO and THRIVE trials over...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryan, Robert, Dayaram, Yaswant K., Schaible, Deborah, Coate, Bruce, Anderson, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960940/
https://www.ncbi.nlm.nih.gov/pubmed/24467642
http://dx.doi.org/10.2174/1570162X12666140128121900

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960940/
https://www.ncbi.nlm.nih.gov/pubmed/24467642
http://dx.doi.org/10.2174/1570162X12666140128121900

Ejemplares similares